04.03. Department of Molecular Biology and Genetics
OrgUnit's Researchers publications
(Dept/Workgroup Publication)
Fulltext
Results 1-16 of 16 (Search time: 0.006 seconds).
| Issue Date | Title | Author(s) | |
|---|---|---|---|
| 1 | 2021 | Advantage of co-culture strategy for targeted cancer treatment and in vitro studies | Ulu, Gizem Tuğçe ; Bayram, Nazende Nur; Dinçer İşoğlu, Sevil; Baran, Yusuf |
| 2 | Mar-2023 | Biodiversity: the overlooked source of human health | Linhares, Yuliya; Kaganski, Alexander; Agyare, Christian; Aksan Kurnaz, Işıl; Neergheen, Vidushi; Kolodziejczyk, Bartlomiej; Baran, Yusuf |
| 3 | 2021 | Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells | Ulu, Gizem Tuğçe ; Bayram, Nazende Nur; Abdulhadi, N.; Gurdap, S.; Isoglu, A.; Isoglu, S. D.; Baran, Yusuf |
| 4 | 2020 | Determination of therapeutic potential of luteolin for Philadelphia chromosome positive acute lymphoblastic leukaemia cells | Gürler, Sevim Beyza; Baran, Yusuf ; Kiraz, Yağmur |
| 5 | 2023 | Foreword | Baran, Y. |
| 6 | 2023 | HER2-specific peptide (LTVSPWY) and antibody (herceptin) targeted core cross-linked micelles for breast cancer: A Comparative study | Bayram, N.N.; Ulu, G.T.; Abdulhadi, N.A.; Gürdap, S.; İşoğlu, İ.A.; Baran, Yusuf ; İşoğlu, S.D. |
| 7 | 28-Oct-2021 | HER2-targeted, degradable core cross-linked micelles for specific and dual pH-sensitive DOX release | Bayram, Nazende Nur; Ulu, Gizem Tuğçe ; Topuzoğulları, Murat; Baran, Yusuf ; Dinçer İşoğlu, Sevil |
| 8 | 2022 | HER2-Targeted, Degradable Core Cross-Linked Micelles for Specific and Dual pH-Sensitive DOX Release | Bayram, N.N.; Ulu, G.T.; Topuzoğulları, M.; Baran, Y. ; Dinçer, İşoğlu, S. |
| 9 | Jul-2022 | Investigating the potential therapeutic role of targeting STAT3 for overcoming drug resistance by regulating energy metabolism in chronic myeloid leukemia cells | Tezcanlı Kaymaz, Burçin; Günel, Nur Selvi; Söğütlü, Fatma; Özateş Ay, Neslihan Pınar; Baran, Yusuf ; Gündüz, Cumhur; Biray Avcı, Çığır |
| 10 | 2023 | MicroRNAs and long non-coding RNAs as novel targets in anti-cancer drug development | Çetinkaya, Melisa; Baran, Yusuf |
| 11 | Apr-2022 | Peptıde targeted core cross-lınked mıcelles for dox delıvery to HER2 expressıng cancer cells | Bayram, Nazende Nur; Ulu, Gizem Tuğçe ; Gürdap, Seda; İşoğlu, İsmail Alper; Baran, Yusuf ; Dinçer İşoğlu, Sevil |
| 12 | 2022 | The role of miRNA in cancer: Pathogenesis, diagnosis, and treatment | Uzuner, Erez; Ulu, Gizem Tuğçe ; Gürler, Sevim Beyza; Baran, Yusuf |
| 13 | 2020 | Synergistic apoptotic effects of bortezomib and methylstat on multiple myeloma cells | Kaci, Fatma Necmiye; Kiraz, Yağmur ; Çekdemir, Demet; Baran, Yusuf |
| 14 | 2023 | Therapeutic potential of luteolin on cancer | Çetinkaya, Melisa; Baran, Yusuf |
| 15 | 2020 | Therapeutic Potentials of Inhibition of Jumonji C Domain-containing Demethylases in Acute Myeloid Leukemia | Koca, Duygu; Hastar, Nurcan; Engür, Selin; Kiraz, Yağmur ; Ulu, Gizem Tuğçe ; Çekdemir, Demet; Baran, Yusuf |
| 16 | 2024 | X. Eğitim çalıştayı raporu | Tanoğlu, Gamze ; Özcan Gönülal, Yasemin ; Baran, Yusuf ; Yürüm, Ozan Raşit; Örün, Özgür; Daver, İlker; Gündüz, Umut Baran |